This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon-like peptide 1.
Clinical and experimental pharmacology & physiology, 51(5), e13854
Citation
Deshmukh, Nitin J; Kalshetti, M S; Patil, Mohan; Autade, Pankaj; Sangle, Ganesh V. (2024). Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon-like peptide 1.. Clinical and experimental pharmacology & physiology, 51(5), e13854. https://doi.org/10.1111/1440-1681.13854